Skip to main content
TERUMO CORPORATION logo

TERUMO CORPORATION — Investor Relations & Filings

Ticker · 4543 ISIN · JP3546800008 LEI · 353800JX1R4582QVK932 T Manufacturing
Filings indexed 89 across all filing types
Latest filing 2026-03-16 Capital/Financing Update
Country JP Japan
Listing T 4543

About TERUMO CORPORATION

https://www.terumo.co.jp/

Terumo Corporation is a global medical technology company that develops, manufactures, and markets a broad portfolio of medical devices, equipment, and solutions. Its core business activities are centered on several key areas: Cardiac and Vascular, Blood and Cell Technologies, and Hospital and Pharmaceutical Solutions. The Cardiac and Vascular business provides products for interventional procedures, neurovascular therapies, and cardiovascular surgery. The Blood and Cell Technologies division offers solutions for blood transfusion, apheresis, and cell therapy processing. The company also supplies general hospital products, including infusion systems and medical disposables, alongside life care products for consumers and specialized pharmaceutical solutions that integrate drugs with delivery devices.

Recent filings

Filing Released Lang Actions
発行登録書(株券、社債券等)
Capital/Financing Update Classification · 95% confidence The document is a 'Shelf Registration Statement' (発行登録書) filed with the Kanto Local Finance Bureau by Terumo Corporation. It outlines the company's intent to issue corporate bonds over a specified period. In the context of Japanese financial regulatory filings, this document is a formal registration for capital raising activities. Since it pertains to financing and capital structure updates, it falls under the 'Capital/Financing Update' category.
2026-03-16 Japanese
訂正発行登録書
Capital/Financing Update Classification · 95% confidence The document is a 'Correction to Shelf Registration Statement' (訂正発行登録書) filed by Terumo Corporation with the Kanto Local Finance Bureau. It relates to the issuance of corporate bonds and updates a previously filed shelf registration statement by incorporating a recently filed extraordinary report (臨時報告書) as a reference document. This falls under capital structure and financing activities, specifically the regulatory process for bond issuance, which is best classified as a Capital/Financing Update (CAP).
2026-02-03 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It specifically references the 'Interim Report' (Hankishokokusho) for the period ending September 30, 2025, and confirms the accuracy of its contents. Since this is a regulatory filing required by law to accompany financial reports and does not fit into the specific categories of the reports themselves, it is classified as a Regulatory Filing.
2025-11-14 Japanese
半期報告書-第111期(2025/04/01-2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) for Terumo Corporation, covering the period from April 1, 2025, to September 30, 2025. It includes detailed financial statements, management analysis, and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2026
2025-11-14 Japanese
訂正発行登録書
Capital/Financing Update Classification · 95% confidence The document is a 'Correction to Shelf Registration Statement' (訂正発行登録書) filed by Terumo Corporation with the Kanto Local Finance Bureau. It serves as a formal regulatory update to a previously filed shelf registration statement (dated March 15, 2024) to incorporate a recently filed extraordinary report. As this is a formal regulatory filing related to capital market registration and does not fit into specific categories like earnings releases or annual reports, it is classified as a Regulatory Filing.
2025-08-25 Japanese
訂正発行登録書
Capital/Financing Update Classification · 95% confidence The document is titled '訂正発行登録書' (Corrected Shelf Registration Statement) and is submitted to the '関東財務局長' (Kanto Local Finance Bureau Director). It explicitly mentions '社債' (Corporate Bonds) as the security type and refers to a previous '発行登録書' (Shelf Registration Statement) from March 15, 2024. The filing date is July 17, 2025. This document is a formal regulatory filing related to the issuance of securities (debt financing), specifically correcting a prior registration. Among the provided codes, 'CAP' (Capital/Financing Update) is the most appropriate category for filings related to debt issuance registration, even if it is a correction, as it pertains directly to capital structure and fundraising activities. It is not a general earnings release (ER) or a comprehensive quarterly report (IR). Since it is a formal, specific regulatory document concerning financing, CAP is preferred over the general RNS fallback.
2025-07-17 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.